Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-133848

Audentes Therapeutics, Inc. · BOLD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 25, 2016
Accepted (ET)
Jul 25, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628738

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 25, 2016C9,000—A475,799D
Common StockF1,F2Jul 25, 2016C13,400—A87,343IBy Asset Management Ventures Fund, L.P.
Common StockF1,F3Jul 25, 2016C2,233—A14,555IBy Camp Lowell Partners, LLC
Common StockF4holding———25,678IBy Amygdala Lange Trust
Common StockF5holding———8,558IBy Lange Minors? Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF1—Jul 25, 2016C9,000D——Common Stock9,0000D
Series B Preferred StockF1,F2—Jul 25, 2016C13,400D——Common Stock13,4000I
Series B Preferred StockF1,F3—Jul 25, 2016C2,233D——Common Stock2,2330I

Explanation of responses